Plain-English translation of NCT06904456 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This research study is observing how people with advanced HIV disease respond when they start antiretroviral therapy (ART) in Zambia. The study will gather information about patients' medical histories, their daily challenges, the services they receive, and how well their treatment works during the first six months—a critical time when many people stop coming to their appointments or face other challenges.
One in five people starting HIV treatment in Zambia has advanced disease, but doctors and health leaders don't have clear information about who these patients are, what they need, or why some do better than others. This study aims to collect that information so health programs can offer better support and make changes that help people survive and stay engaged with their care.
You likely qualify if…
You likely don't qualify if…
Depending on which group you join, you may complete surveys about your health and life circumstances, participate in group discussions or interviews about your HIV care experiences, or allow researchers to review your medical records for up to 12 months before and after you start treatment. Most participants will visit the clinic for their regular HIV care appointments, and researchers will collect information during those visits. The study follows you for at least six months as you begin your treatment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Zambia